These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 10608466

  • 1. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
    Magga J, Kalliovalkama J, Romppanen H, Vuolteenaho O, Pörsti I, Kähönen M, Tolvanen JP, Ruskoaho H.
    J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N, Sugano M, Otsuka S, Hata T.
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic.
    Wang X, Nishikimi T, Akimoto K, Tadokoro K, Mori Y, Minamino N.
    J Hypertens; 2003 Jun; 21(6):1171-81. PubMed ID: 12777955
    [Abstract] [Full Text] [Related]

  • 4. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y.
    Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
    [Abstract] [Full Text] [Related]

  • 5. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H.
    Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
    [Abstract] [Full Text] [Related]

  • 6. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
    Kalliovalkama J, Kähönen M, Tolvanen JP, Wu X, Voipio J, Pekki A, Doris PA, Ylitalo P, Pörsti I.
    Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy.
    Thomas CJ, Head GA, Woods RL.
    Hypertension; 1998 Sep; 32(3):548-55. PubMed ID: 9740624
    [Abstract] [Full Text] [Related]

  • 9. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M, Kalliovalkama J, Pörsti I, Jolma P, Tolvanen JP, Vuolteenaho O, Ruskoaho H.
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [Abstract] [Full Text] [Related]

  • 10. Atrial natriuretic factor and brain natriuretic peptide gene expression in the spontaneous hypertensive rat during postnatal development.
    Kuroski de Bold ML.
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):1006-18. PubMed ID: 9715795
    [Abstract] [Full Text] [Related]

  • 11. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
    Nakano N, Moriguchi A, Morishita R, Kida I, Tomita N, Matsumoto K, Nakamura T, Higaki J, Ogihara T.
    Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
    [Abstract] [Full Text] [Related]

  • 12. Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats.
    Varo N, Iraburu MJ, Varela M, López B, Etayo JC, Díez J.
    Hypertension; 2000 Jun; 35(6):1197-202. PubMed ID: 10856263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
    Dukacz SA, Kline RL.
    J Hypertens; 1999 Sep; 17(9):1345-52. PubMed ID: 10489114
    [Abstract] [Full Text] [Related]

  • 15. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
    Nunez E, Hosoya K, Susic D, Frohlich ED.
    Hypertension; 1997 Jan; 29(1 Pt 2):519-24. PubMed ID: 9039153
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.
    Kinnunen P, Vuolteenaho O, Ruskoaho H.
    Endocrinology; 1993 May; 132(5):1961-70. PubMed ID: 8477647
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
    Peng F, Lin J, Lin L, Tang H.
    Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
    [Abstract] [Full Text] [Related]

  • 20. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G, Hertenberg F, Wetzels JF, Smits P.
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.